Published in Heart Fail Rev on November 01, 2011
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf) (2013) 1.26
Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic review. Clin Chem Lab Med (2012) 0.98
Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin. Heart Fail Rev (2014) 0.87
Role of neutrophil gelatinase-associated lipocalin for early detection of acute kidney injury. Int J Crit Illn Inj Sci (2014) 0.76
Patients with cardiorenal syndrome revealed increased neurohormonal activity, tubular and myocardial damage compared to heart failure patients with preserved renal function. Cardiorenal Med (2014) 0.76
The role of natriuretic peptides for the diagnosis of left ventricular dysfunction. ScientificWorldJournal (2013) 0.75
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet (2005) 13.77
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med (2002) 12.95
Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int (2002) 8.03
Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem (1998) 5.99
Biomarkers in heart failure. N Engl J Med (2008) 5.20
Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol (2008) 4.56
Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int (2006) 3.96
Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis (2008) 3.95
Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol (2005) 3.94
Natriuretic peptides. J Am Coll Cardiol (2007) 3.91
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol (2005) 3.85
Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology (2006) 3.66
Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J (2009) 3.52
Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol (2007) 3.48
Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care (2007) 3.29
Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int (2007) 3.23
Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics (1997) 3.16
Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int (2008) 3.12
NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol (2007) 2.99
A rapid urine test for early detection of kidney injury. Kidney Int (2009) 2.50
Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol (2005) 2.34
Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol (2004) 2.27
Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann Thorac Surg (2009) 2.19
Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract (2008) 2.03
Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol (2007) 1.82
Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers (2009) 1.77
Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol (2007) 1.69
Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail (2008) 1.67
Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif (2009) 1.55
Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin Biochem (2009) 1.50
Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease. Kidney Blood Press Res (2009) 1.33
NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol (2009) 1.22
Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors. J Hypertens (1992) 1.20
Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant (2009) 1.20
Urine neutrophil gelatinase-associated lipocalin and interleukin-18 predict acute kidney injury after cardiac surgery. Ren Fail (2008) 1.18
Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. Rejuvenation Res (2009) 1.09
The epidemiology of cardiac surgery-associated acute kidney injury. Int J Artif Organs (2008) 1.08
Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant (2010) 1.07
Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study. Eur Heart J (2009) 1.04
Cystatin C in acute heart failure without advanced renal impairment. Am J Med (2009) 1.03
Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol (2007) 0.99
Urinary interleukin-18 does not predict acute kidney injury after adult cardiac surgery: a prospective observational cohort study. Crit Care (2008) 0.99
Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail (2009) 0.95
Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study). Am J Cardiol (2008) 0.94
Cystatin C as a reliable marker of renal function following heart valve replacement surgery with cardiopulmonary bypass. Clin Chim Acta (2006) 0.93
Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Am J Cardiol (2009) 0.92
Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome. Atherosclerosis (2009) 0.89
Usefulness of cystatin C and prognosis following admission for acute heart failure. Am J Cardiol (2009) 0.87
Assessment of glomerular filtration rate by serum cystatin C in patients undergoing coronary artery bypass grafting. Ann Clin Biochem (2009) 0.83
Performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Abbott ci8200 analyzer. Clin Biochem (2009) 0.83
Cardiorenal syndrome: biomarkers linking kidney damage with heart failure. Biomark Med (2009) 0.78
Performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Hitachi 917 analyzer. Clin Chim Acta (2008) 0.77
Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome. Rev Esp Cardiol (2009) 0.76
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89
Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA (2005) 19.57
An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med (2006) 6.87
Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA (2009) 6.55
Acute kidney injury. Lancet (2012) 4.90
The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol (2011) 4.57
Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J (2009) 3.52
Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol (2007) 3.17
Diuretics and mortality in acute renal failure. Crit Care Med (2004) 3.12
A wearable haemodialysis device for patients with end-stage renal failure: a pilot study. Lancet (2007) 3.04
Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med (2007) 3.03
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med (2015) 2.97
Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med (2005) 2.85
Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol (2002) 2.83
Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol (2008) 2.76
Defining acute renal failure: physiological principles. Intensive Care Med (2003) 2.69
External validation of severity scoring systems for acute renal failure using a multinational database. Crit Care Med (2005) 2.68
Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut (2011) 2.65
Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med (2009) 2.58
A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury. Nephrol Dial Transplant (2009) 2.55
Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med (2009) 2.53
North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE Criteria. Clin J Am Soc Nephrol (2007) 2.50
Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care (2008) 2.36
Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care (2003) 2.36
Fluid balance and acute kidney injury. Nat Rev Nephrol (2009) 2.23
The pathogenesis of septic acute renal failure. Curr Opin Crit Care (2003) 2.16
Patients with acute heart failure in the emergency department: do they all need to be admitted? J Card Fail (2012) 2.09
Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care (2009) 2.03
Clinical review: RIFLE and AKIN--time for reappraisal. Crit Care (2009) 2.00
Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria. Nat Rev Nephrol (2011) 1.99
Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM. Intensive Care Med (2010) 1.98
Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant (2013) 1.96
Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med (2006) 1.91
The first international consensus conference on continuous renal replacement therapy. Kidney Int (2002) 1.89
Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care (2011) 1.86
Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol (2005) 1.84
Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J Am Soc Nephrol (2008) 1.82
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care (2007) 1.80
Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant (2005) 1.78
The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease. Am Heart J (2007) 1.69
Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med (2005) 1.69
Assessment of intermediate severity coronary lesions in the catheterization laboratory. J Am Coll Cardiol (2007) 1.68
Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. Am Heart J (2007) 1.67
BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail (2004) 1.66
Fluid balance as a biomarker: impact of fluid overload on outcome in critically ill patients with acute kidney injury. Crit Care (2008) 1.64
Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department. Clin Chem Lab Med (2013) 1.63
A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med (2002) 1.61
Subclinical AKI is still AKI. Crit Care (2012) 1.59
Cerebral salt wasting and elevated brain natriuretic peptide levels after traumatic brain injury: 2 case reports. Surg Neurol (2008) 1.57
Arteriovenous fistula toxicity. Blood Purif (2011) 1.57
Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif (2009) 1.55
TakoTsubo cardiomyopathy: unravelling the malignant consequences of a benign disease with cardiac magnetic resonance. Heart Fail Rev (2015) 1.49
Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosis. J Hypertens (2015) 1.46
Kidney attack. JAMA (2012) 1.46
Improving outcomes from acute kidney injury. J Am Soc Nephrol (2007) 1.42
Consensus development in acute renal failure: The Acute Dialysis Quality Initiative. Curr Opin Crit Care (2005) 1.40
Biosimilars and safety issues. Leuk Lymphoma (2009) 1.40
Primary prevention of acute renal failure in the critically ill. Curr Opin Crit Care (2005) 1.40
Do not dialyze. Int J Artif Organs (2006) 1.40
Definition and classification of acute kidney injury. Nephron Clin Pract (2008) 1.39
Oxidative stress and 'monocyte reprogramming' in septic patients with acute kidney injury requiring CRRT. Blood Purif (2008) 1.39
Depressive symptoms and spiritual wellbeing in asymptomatic heart failure patients. J Behav Med (2014) 1.38
Brain natriuretic peptide is removed by continuous veno-venous hemofiltration in pediatric patients. Interact Cardiovasc Thorac Surg (2009) 1.38
Improving outcomes of acute kidney injury: report of an initiative. Nat Clin Pract Nephrol (2007) 1.38
National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. J Am Coll Cardiol (2010) 1.37
Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol (2013) 1.37
Cardiopulmonary bypass-associated acute kidney injury: a pigment nephropathy? Contrib Nephrol (2007) 1.34
Epidemiology of acute kidney injury. Contrib Nephrol (2010) 1.33
Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med (2012) 1.32
N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis. Circ Heart Fail (2012) 1.31
Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified Delphi process. Clin J Am Soc Nephrol (2008) 1.30
Subclinical AKI--an emerging syndrome with important consequences. Nat Rev Nephrol (2012) 1.29
Pre-renal azotemia: a flawed paradigm in critically ill septic patients? Contrib Nephrol (2007) 1.29
Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care (2013) 1.29
B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation (2002) 1.28
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab (2012) 1.27
Improving outcomes from acute kidney injury: report of an initiative. Am J Kidney Dis (2007) 1.26
Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant (2010) 1.22
NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol (2009) 1.22
Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2010) 1.20
A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J (2002) 1.16
Improving outcomes from acute kidney injury: report of an initiative. Pediatr Nephrol (2007) 1.15
S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea. Ann Emerg Med (2009) 1.15
Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Am Heart J (2006) 1.15
B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J (2004) 1.14
Acute kidney injury: classification and staging. Contrib Nephrol (2010) 1.14
In vivo validation of the adequacy calculator for continuous renal replacement therapies. Crit Care (2005) 1.12
Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2013) 1.11
Patient Selection and Timing of Continuous Renal Replacement Therapy. Blood Purif (2016) 1.10
RIFLE criteria for cardiac surgery-associated acute kidney injury: risk factors and outcomes. Congest Heart Fail (2010) 1.10
Hospital-acquired acute kidney injury in the elderly. Nat Rev Nephrol (2010) 1.10
The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study. J Card Fail (2009) 1.08
Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Am J Cardiol (2006) 1.08
Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care (2005) 1.08